Seah LIm
Vermogen: 41 474 $ op 30-06-2026
Vermogen: 41 474 $ op 30-06-2026
Seah H.
LIm is the founder of Medicovestor, Inc. Currently, Dr. LIm is the Director of the Adult Sickle Cell Program at SUNY Upstate Medical University since 2021.
Formerly, Dr. LIm was the Chief Executive Officer of Medicovestor Bio Plc and served as an Independent Director at Emmaus Life Sciences, Inc. from 2022 to 2024.
Dr. LIm earned doctorates from the University of Aberdeen and The University of Wales.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-03-2025 | 4.147.426 ( 5,91% ) | 41 474 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
SUNY Upstate Medical University
SUNY Upstate Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-10-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
| EMMAUS LIFE SCIENCES, INC. | Directeur/Bestuurslid | 04-11-2024 |
Medicovestor Bio Plc | Algemeen Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
University of Aberdeen
University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SUNY Upstate Medical University
SUNY Upstate Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Wales
The University of Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emmaus Life Sciences, Inc.
Emmaus Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments and therapies for rare diseases | Health Technology |
Medicovestor Bio Plc |
Kies jouw editie
Alle financiële informatie op nationaal niveau